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Background: Loss of muscle mass and muscle strength are natural consequences of the aging process,
accompanied by an increased prevalence of chronic health conditions. Research suggests that in the elderly, the
presence of comorbidities may impact the muscle mass/strength relationship. The objectives of this study were to
characterize the muscle mass/strength relationship in older adults in the USA and to examine the impact of a
variety of comorbidities on this relationship.
Methods: Data were obtained from the National Health and Nutrition Examination Survey 1999–2002 databases.
Subjects aged 50 years and older were included in the present study. Muscle mass was assessed by height-adjusted
appendicular skeleton muscle mass (aASM) in kg/m2, as measured by dual-energy x-ray absorptiometry. Muscle
strength was assessed via isokinetic quadriceps strength (IQS) in newton as measured by a dynamometer. The
relationship between aASM and IQS was assessed adjusting for age and gender. The effects of a variety of
comorbidities on IQS and/or on the relationship between IQS and aASM were assessed using multiple regression
models.
Results: This study included 2,647 individuals, with a mean age of 62.6 years and 52.9% of whom were female.
The mean (SE) aASM (kg/m2) was 7.3 (0.04), and the mean (SE) IQS (newton) was 365.0 (3.00). After adjusting for
age and gender, the correlation coefficient between aASM and IQS was 0.365 (P < 0.001). Diabetes, coronary heart
disease/congestive heart failure (CHD/CHF), and vision problems were significant predictors of lower muscle
strength (P < 0.05) in the multiple regression models that adjusted for age, gender, and aASM, and obesity
significantly modified the relationship between aASM and IQS (P < 0.05).
Conclusions: Among individuals aged 50 and older in the US, muscle mass and muscle strength are positively
correlated, independent of the associations of age and gender with muscle mass and strength. A variety of
comorbid medical conditions serve as independent predictors of lower muscle strength (e.g., diabetes, CHD/CHF,
vision problems) and/or modify the relationship between muscle mass and muscle strength (e.g., obesity).
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By the year 2020, there are projected to be almost 55
million Americans, in the USA, over the age of 65 and
more than 6 million over the age of 85 [1]. One conse-
quence of the aging of the population will be an increase
in the number of Americans who will experience the
predictable loss of muscle mass and muscle strength that
occurs with aging [2]. While not necessarily pathological,
this age-related loss of muscle mass and strength has
been shown to have important health consequences
[3,4], predisposing the elderly to falls and contributing
to other functional limitations [5,6].
Although the positive correlation between muscle
mass and muscle strength has been well established
[2,7-11], it is not clear whether higher muscle mass
necessarily translates into greater muscle strength or
whether gains in muscle strength cannot be achieved
without corresponding gains in muscle mass. For ex-
ample, Park et al. (2006) and colleagues found in the
Health, Aging, and Body Composition (Health ABC)
study that, while older adults with type II diabetes had
higher muscle mass compared with their non-diabetic
counterparts, they did not exhibit greater muscle
strength [12]. Similarly, Raue and colleagues, studying
the impact of conditioning on muscle mass and muscle
strength in octogenarian women, found that whole
muscle strength increased with resistance training,
while muscle mass did not increase [13].
A number of clinical conditions have also been shown
to correlate with muscle mass and/or strength, and it is
possible that heterogeneity among older adults with
respect to these conditions, many of which are increas-
ingly prevalent with age [14], may contribute to the
indeterminate relationship between muscle mass and
muscle strength. While several studies corroborate the
impact of comorbid conditions such as diabetes, obesity,
and osteoarthritis on muscle mass, muscle strength, or
related functional outcomes [12,15-18], no study has sys-
tematically explored the complex interactions between
these conditions and muscle mass and strength.
In the present study, we aimed to better understand the
relationship between muscle mass and muscle strength in
US older adults, and to examine the impact of a variety of
comorbidities on muscle strength and the relationship
between muscle mass and muscle strength. Our specific
objectives were as follows: (1) to describe muscle mass
and muscle strength, stratified by age and gender; (2) to
assess the degree to which muscle mass and strength are
correlated, adjusting for the effects of age and gender; and
(3) to explore the impact of a variety of comorbid condi-
tions on muscle strength and/or the relationship between
muscle mass and strength. For the latter objective, our
general hypothesis was that certain factors, such as obesity
and arthritis, might limit the degree to which highermuscle mass translates into greater muscle strength. In-
sights gained from these analyses could aid in the manage-
ment of patients, who have muscle atrophy or wasting
by providing norms and targets for rehabilitation and




This was a cross-sectional, population-based study that
used data from men and women 50 years and older who
were enrolled in the National Health and Nutrition Exam-
ination Survey (NHANES) 1999–2002. The NHANES
performs a continuous, nationally representative health
survey of the civilian, non-institutionalized U.S. popula-
tion and collect data on approximately 5,000 persons each
year from in-person interviews, physical examinations,
and medical tests. To produce nationally representative
estimates, NHANES has adopted a complex, multistage,
probability sampling design, and the survey oversamples
certain ethnic minorities and individuals aged 60 years
and older [19]. In 1999, NHANES began performing dual-
energy x-ray absorptiometry (DXA) whole body examina-
tions, and providing data on body composition, such as
lean mass for total body and for each arm and leg, head,
and trunk. The DXA equipment used was a Hologic QDR
4500A fan beam densitometer [20]. During 1999–2002,
NHANES also collected data on muscle strength as mea-
sured by the isokinetic strength of the knee extensors
using a Kin Com MP dynamometer [21], which enabled
the study of both muscle mass and muscle strength. A
total of 2,647 men and women, 50 years of age and
older, with muscle mass and muscle strength data available
from the NHANES 1999–2002, were included in the
present study.
Measures
Muscle mass was assessed using lean mass, excluding
bone mineral content (BMC), obtained from DXA scan.
In previous research, lean mass, excluding BMC, has
been shown to validly represent skeletal muscle mass in
the extremities [22]. In our study, appendicular skeletal
muscle mass (ASM) for each subject was calculated as
the sum of lean mass, excluding BMC, in both arms and
both legs. A height-adjusted index (aASM) was then
calculated by dividing a subject’s ASM in kilograms (kg)
by the subject’s height in meters squared (m2) [23,24].
This index, expressed in kg/m2, was the muscle mass
measure used for all analyses.
Muscle strength was established using measurement of
the isokinetic strength of the knee extensors at peak
force (isokinetic quadriceps strength [IQS]), in newtons
[21]. There is evidence that lower extremity strength is
associated with physical function, an important component
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six measurements of right quadriceps muscle strength
were taken, three warm-up trial measurements followed
by three outcome measurements. If a survey participant
completed 4 to 6 measures, the highest peak force was
selected from trials 4 to 6. If a survey participant had
completed fewer than 4 trials, the highest peak force from
the warm-up trials was selected. The IQS, expressed as
newtons at one speed (60 degrees/second) on the right
side, was the muscle strength measure used for all
analyses.
Comorbidity data were obtained from self-reported
personal interview questionnaire data collected in the
NHANES. Presence of a variety of health conditions,
which potentially affect muscle mass and/or strength,
was assessed using data from the medical conditions/his-
tory questionnaire, including the following: diabetes;
coronary heart disease (CHD) (including heart attack/
myocardial infarction)/congestive heart failure (CHF);-
vision problems; obesity; arthritis (including both rheuma-
toid and osteoarthritis); asthma; osteoporosis; cancer
(multiple varieties, excluding skin cancer); and chronic
bronchitis/emphysema. Body mass index (BMI) was also
investigated and defined as weight (kg) divided by height
squared (m2). Consistent with the recommendation from
Center for Disease Control and Prevention [26], the fol-
lowing four categories of BMI were adopted in this
study: BMI < 18.5 kg/m2 (underweight), 18.5-24.99 (healthy
weight), 25–29.99 (overweight), and ≥30 (obese).
Statistical analyses
Statistical procedures were employed that made use of
the information from the complex, multistage, probabil-
ity sampling design of the NHANES. Sampling weights
were used to create mean estimates that were nationally
representative of the older adult population, taking ad-
vantage of the oversampling of subjects in particular age,
racial, and ethnic groups. All statistical analyses were
design-based, except the partial correlation coefficient
calculation that used raw, un-weighted data.
Distributions of aASM and IQS, by gender and age
group (in five-year intervals), were presented using box
plots. The box plots present the mean, 5th, 25th, 50th (me-
dian), 75th and 95th percentiles. The Pearson partial correl-
ation coefficient, controlling for age and gender, was used
to examine the association between aASM and IQS.
Multiple regression models, using survey strata and
weighting, were conducted to examine the effect of each
comorbidity on IQS and on the relationship between
aASM and IQS. We first constructed a linear regression
model on IQS with aASM as an exploratory variable,
adjusting for age and gender (Model 1). Next, for each
comorbidity, we built two additional linear regression
models on IQS, one with the studied comorbidity as anexploratory variable, adjusting for aASM, age and gender
(Model 2), and another with all variables in Model 2,
plus the interaction between aASM and the comorbidity
of interest (Model 3). The regression coefficients for
aASM and the studied comorbidity were presented,
including the 95% confidence intervals (CIs), along with
the significance level of the interaction term from Model
3. Where results suggested a significant interaction be-
tween aASM and a given comorbidity, the relationship
between aASM and IQS was graphically presented via
scatter plot by using the raw non-weighted data, along
with the age- and gender-adjusted regression lines, via
Model 3 and stratifying on comorbidity status. In addition,
subgroup analyses of linear regression models (Model 1)
were fit within comorbidity subgroups (e.g., arthritis and
non-arthritis subgroups), adjusting for age and gender.
All analyses were conducted using SAS®, version 9.2
survey procedures (SAS Institute, Cary, North Carolina,
USA). All hypothesis tests were 2-tailed with a signifi-
cance level of 0.05, and regression coefficients were
deemed significantly different if the corresponding 95%
CIs were non-overlapping.Results
Population characteristics are presented in Table 1. The
sample represented a population with a mean (SE) age
of 62.6(0.32) years of age, 52.9% female and 80.9% non-
Hispanic white. The mean (SE) aASM was 7.3 (0.04) kg/
m2, and the mean (SE) IQS was 365.0 (3.0) newtons.
The distributions of aASM and IQS, stratified by gen-
der and age, are presented in Figure 1 and Figure 2, re-
spectively. Both aASM and IQS tend to decrease with
age in older adult men and women, and women appear
to have a lower mean aASM and IQS than men within
the same age group. In men, aASM appears to decrease
steadily after age 65, while a similar decrease in women
occurs somewhat later (Figure 1). Mean IQS tends to de-
cline in both men and women as early as the starting
age of the study cohort (the sixth decade of life), with
the IQS decline in men appearing somewhat steeper
than for women.
The correlation coefficient between aASM and IQS,
after adjusting for age and gender, was 0.365 (P < 0.001);
in other words, the coefficient of partial determination
was 0.133 (0.3652) [27], which indicates that aASM
explained 13.3% of variance in IQS, independent of the
effect of age and gender. Results from the multiple linear
regression models, presented in Table 2, provided add-
itional statistically significant evidence that supports the
association between aASM and IQS. After adjusting for
age and gender, the regression coefficient for aASM was
31.6 (95% CI: 27.2,36.0), representing, on average, a 31.6
(95% CI: 27.2,-36.0) newton increase in IQS for every 1
Table 1 Baseline study sample characteristics
Characteristics Mean (SE) or n(%) of Population a
Age (years), mean (SE) 62.6 (0.32 )












Non-Hispanic White 1528 (80.9%)
Mexican American 517 (3.3%)
Other Hispanic 120 (5.1%)
Non-Hispanic Black 413 (7.4%)
Other Race - Including Multiracial 69 (3.2%)





aASM (kg/m2), mean (SE) 7.3 (0.04)
IQS (newton), mean (SE) 365.0 (3.00)
Abbreviations: aASM height-adjusted appendicular skeleton muscle mass,
IQS isokinetic quadriceps strength.
aAll percentage and mean estimates were weighted according to
sampling design.
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together, explained 59.9% of the variance in IQS.
Results from the multiple regression models that in-
corporated each of the comorbidities suggested that dia-
betes, CHD/CHF, and vision problems had significant
negative main effects on IQS (P < 0.05), while correspond-
ing interaction effects between the comorbidity and aASM
were not statistically significant (P > 0.05) (Table 2). Specif-
ically, individuals with diabetes, CHD/CHF, and vision
problems demonstrated an IQS, on average, of −27.1 (95%
CI: -42.1,-12.0), -20.7 (95% CI: -36.1,-5.3) and −20.1 (95%
CI: -34.4, -5.7) newtons less, respectively, than the age,
gender, and aASM comparable older adults without these
comorbid conditions.
Body mass index, arthritis, and osteoporosis had both
significant main effects and interaction effects on IQS,
while asthma had a significant interaction effect, but an
insignificant main effect on IQS, which made the corre-
sponding regression coefficients less directly interpretable.Cancer and bronchitis/emphysema had neither significant
main nor interaction effects.
The relationship between muscle mass and IQS among
subgroups with and without the comorbidities for which
there were significant interaction effects (e.g., obesity,
arthritis, asthma, and osteoporosis) is shown visually in
Figure 3. Subgroup analyses suggested that the regres-
sion slopes for aASM were comparable among under-
weight (47.9 [95% CI: 20.4,74.0], healthy weight (54.4
[95% CI: 42.3,66.5]) and overweight subgroups (47.4
[95% CI: 38.5,56.4]), while the slope for the obese sub-
group (23.8 [95% CI: 13.1,34.4]) differed significantly
from that of both the healthy weight and overweight
subgroups. As such, for simplicity, the influence of
weight was shown in the Figure 3A by stratifying sub-
jects into only two subgroups, obese and non-obese. As
shown in this figure, obese subjects (red diamonds) tend
to have, on average, lower strength at a given aASM
value compared to non-obese subjects (blue squares),
and the regression line for this subgroup (red line) is
consistently below that for the non-obese subgroup.
In Figure 3B, the regression line for the non-arthritis
subgroup was generally higher than that for the arth-
ritis subgroup. While the difference in the slopes of
these regression lines was not statistically significant,
the regression lines can be seen to diverge as aASM
increases and to become closer and eventually to cross
at lower values of aASM. A similar pattern was seen for
subgroups with and without osteoporosis and asthma
(Figure 3C and 3D).
Discussion
In this cross-sectional, population-based study of older
US adults, we described the distribution of muscle mass
and muscle strength stratified by age and gender. We
found that muscle mass and muscle strength were posi-
tively correlated after adjusting for age and gender. We
also found that certain comorbidities had significant
impacts on muscle strength and/or on the relationship
between muscle mass and muscle strength.
To our knowledge, this is the first study to characterize
the distribution of height-adjusted appendicular skeletal
muscle mass in a nationally representative sample of older
adults in the US. Kelly et al. (2009) provided nationally
representative reference data on DXA body composition
reference values, but did not include reference data on
lean mass exclusive of bone mineral content, which is
considered a better representation of skeletal muscle mass
[24]. The distributions of aASM and IQS can serve as
reference values for US older adults and may prove useful
in the evaluation of abnormalities involving muscle mass
and muscle strength.
In this study, we observed that both muscle mass and



















Figure 1 Distribution of muscle mass by age and gender. Lower half of boxplot depicts 25th percentile, upper half of boxplot represents
75th percentile, horizontal line dividing upper and lower half of boxplot represents median, upper whisker represents 95th percentile, lower
whisker represents 5th percentile; and solid diamond in boxplot represents mean. aASM = height-adjusted appendicular skeleton muscle mass.
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mass and strength compared with men of the same age,
and these findings are consistent with previous research
[8-10,28-30]. Our observation that age-associated decre-
ments were more pronounced for muscle strength than


















Figure 2 Distribution of muscle strength by age and gender. Lower h
75th percentile, horizontal line dividing upper and lower half of boxplot re
whisker represents 5th percentile; and solid diamond in boxplot representslongitudinal study of 1,880 older adults; this finding
showed that muscle quality (defined as muscle strength
per unit of muscle mass) declines with advancing age
[31].
This study quantified the positive association between




alf of boxplot depicts 25th percentile, upper half of boxplot represents
presents median, upper whisker represents 95th percentile, lower
mean. IQS = Isokinetic quadriceps strength.
Table 2 Results of multiple linear regression modeling on muscle strengtha









Significant level of the interaction
effect (aASM by studied variable)e
aASMc — 31.6 (27.2, 36.0)*** — —
Diabetes 364 (10%) 32.7(28.3, 37.0)*** −27.1 (12.0, 42.1)** NS
Coronary Heart Disease/
Congestive Heart Failure
177 (10%) 34.5(29.3, 39.8)*** −20.7 (−36.1, -5.3)* NS
Vision Problem 366 (19%) 34.0(28.7, 39.2)*** −20.1 (−34.4, -5.7)* NS
BMI — 46.4 (38.1, 54.7)*** −3.7 (−5.4, -2.1)** *
Arthritis 638 (39%) 35.1(29.9, 40.4)*** −19.6 (−27.4, -11.8)*** *
Asthma 158 (11%) 34.1 (28.8, 39.5)*** −6.4 (−26.3, 13.6) **
Osteoporosis 189 (8%) 31.8(27.4, 36.2)*** −12.3 (−22.0, -2.6)* **
Cancer 222 (14%) 34.3(28.9, 39.8)*** 6.7 (−6.1, 19.6) NS
Chronic Bronchitis /
Emphysema
136 (9%) 34.0(28.7, 39.4)*** −9.2 (−20.6, 2.3) NS
Abbreviations: aASM height-adjusted appendicular skeleton muscle mass, BMD bone mass density, BMI body mass index, CI confidence interval,
NS not significant (P > 0.05).
aAll estimates weighted according to sampling design.
bProportions are calculated based on subjects with non-missing data.
cModel 1: Exploratory variables include aASM, age, and gender.
dModel 2: Exploratory variables include the studied variable, aASM, age, and gender.
eModel 3: Exploratory variables include the studied variable, aASM, studied variable by aASM interaction, age, and gender.
*P < 0.05, **P < 0.01, ***P < 0.001.
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in muscle strength, independent of age and gender. After
adjusting for age and gender, every one unit increase in
aASM was associated with a corresponding 31.6 newton
increase in IQS. As these results are derived from a
cross-sectional study, any causal inference is precluded.
Nevertheless, these data underscore the need for further
prospective research that evaluates the downstream
effects of interventions, which are aimed at preserving
muscle mass, on muscle strength and physical function.
Our study also revealed that certain comorbidities im-
pact muscle strength or the muscle mass/strength rela-
tionship. Diabetes, CHD/CHF, and vision problems were
independent predictors of low muscle strength, which
suggests that individuals with these comorbidities have,
on average, lower muscle strength compared with indi-
viduals of similar age, gender, and muscle mass. Our
finding regarding the effect of diabetes is consistent with
work conducted by Park et al. (2006), wherein diabetics
in the Health ABC Study were observed to have poorer
muscle quality than non-diabetics [12]. Older diabetic
men and women in that study exhibited greater muscle
mass without a corresponding increase in muscle strength
relative to non-diabetic older adults. Research in exercise
physiology has established a robust dose–response rela-
tionship between physical exercise and muscular adapta-
tion, which leads to increased motor unit activation and a
proportionately greater increase in muscle strength than
in muscle mass [32]. Conversely, decreased physical activ-
ity is a known risk factor for diabetes [33], and diabetics,on average, are likely to exhibit poorer muscle quality rela-
tive to their non-diabetic peers. In addition, vascular and
metabolic deficits (e.g., decreased oxygen supply or im-
paired glucose extraction and utilization by muscle) may
also contribute to physiologic impairment of muscle cells
in diabetics, which results in diminished muscle strength.
Deconditioning, likely, also contributes to the decrease in
muscle strength that is observed in subjects with CHD/
CHF, vision problems, and obesity, as these groups may be
more limited in their ability to engage in regular physical
activity. In addition, the increase in intramyocellular fat,
which is seen in obese subjects, may also adversely affect
muscle quality and force production, although the mech-
anism for this result is unclear [12].
While arthritis, asthma and osteoporosis all appeared
to alter the relationship between muscle mass and
muscle strength to some extent, interpretation of these
effects is challenging due to the significant interaction
effects observed. It is possible that these conditions are
meaningful effect modifiers, but the results from our
subgroup analyses (e.g., absence of statistically significantly
differences in regression line slopes) failed to establish this.
It may be that these effects are relatively marginal or
perhaps more complex (e.g., non-linear), thus, requiring a
larger sample size or more complex modeling approaches.
Further research is warranted to better understand the
effects of these comorbidities.
These findings should be interpreted in the context of
study limitations. First, the cross-sectional nature of the
data limits our ability to do more than describe asso-
A B
C D
Figure 3 Correlation between muscle mass and muscle strength: the modification effect of comorbidities (A. Obesity, B. Arthritis,
C. Asthma, D. Osteoporosis). aASM = height-adjusted appendicular skeleton muscle mass; IQS = isokinetic quadriceps strength.
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better understand the causal nature of these associations.
Second, comorbidities were based upon self-report, rather
than on formal clinical assessment, which raises concerns
about recall and other biases. Finally, comorbidities were
examined individually; whereas, in many cases, multiple
comorbidities may co-occur. Unfortunately, incorporating
additional two-way or three-way interaction effects would
have significantly impacted the power available to draw
meaningful conclusions.Conclusions
In conclusion, among individuals aged 50 and older in
the US, muscle mass and muscle strength are positively
correlated, independently of the associations of age and
gender with muscle mass and strength. Certain comor-
bid medical conditions serve as independent predictors of
lower muscle strength (e.g., diabetes, CHD/CHF, visionproblems) or modify the relationship between muscle
mass and muscle strength (e.g., obesity).
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